期刊文献+

秋龙筋中药制剂对链脲佐菌素诱导糖尿病大鼠的降糖作用及机制研究 被引量:1

Study on hypoglycemic effect and related mechanism of Qiulongjin Chinese medicine preparation on STZ-induced diabetic rats
下载PDF
导出
摘要 目的探讨秋龙筋中药制剂对链脲佐菌素(STZ)诱导糖尿病大鼠的降糖作用及作用机制,为进一步深入开发提供依据。方法将24只大鼠分为正常组、模型组、阳性药组及实验组,模型组、阳性药组及实验组使用STZ诱导造模。正常组及模型组给予生理盐水,阳性药组给予盐酸二甲双胍,实验组给予秋龙筋中药制剂干预。给药结束后检测血清学指标;采集肝脏组织,检测肝糖原水平。结果实验组大鼠血中低密度脂蛋白胆固醇(LDL-C)、血清总胆固醇(TC)、三酰甘油(TG)、空腹血糖(FBG)、丙二醛(MDA)、游离脂肪酸(FFA)、糖化血红蛋白(GHb)、一氧化氮(NO)、肿瘤坏死因子-α(TNF-α)水平明显低于模型组,高密度脂蛋白胆固醇(HDL-C)、超氧化物歧化酶(SOD)、谷胱甘肽(GSH)、肝糖原水平明显高于模型组(P<0.05)。结论采用秋龙筋中药制剂对STZ诱导糖尿病大鼠干预后,可有效降低其体内血糖水平,提高胰腺β细胞功能。 Objective To study the hypoglycemic effect and mechanism of Qiulongjin Chinese medicine preparation on STZ-induced diabetic rats.Methods Twenty-four rats were divided into the normal group,model group,positive drug group and experimental group.The model group,positive drug group and experimental group used STZ to induce the model construction.The normal group and model group were given normal saline,the positive drug group was given metformin hydrochloride,and the experimental group was given Qiulongjin Chinese medicine preparation intervention.The serological indexes were detected at the end of medication.Liver tissue was collected and liver glycogen level was detected.Results The levels of LDL-C,TC,TG,FBG,MDA,FFA,GHb,NO and TNF-αin the experimental group were significantly lower than those in the model group,while the levels of HDL-C,SOD,GSH and liver glycogen were significantly higher than those in the model group(P〈0.05).Conclusion Adopting Qiulongjin Chinese medicine preparation for conducting the intervention on STZ-induced diabetic rats could effectively decrease the blood glucose level and increases the pancreaticβcellular function.
作者 林文东 杨维群 施水液 张美佳 程晶 洪建兵 LIN Wendong1 ,YANG Wiequn1 , SHI Shuiye2 , ZHANG Meijia2 , CHENG Jing1 , HONG Jianbing3(1. Department of Basic Medicine , Quanzhou Medical College, Quanzhou, Fujian 362000, China ; 2. Internal Medicine ,Jinjiang Municipal Hospital of Integrated Traditional Chinese and Western Medicine, Jinjiang, Fujian 362200, China ; 3. Fujian Spring Star Biological Co. ,Ltd Nanan, Fujian 362300, Chin)
出处 《重庆医学》 CAS 2018年第24期3138-3141,共4页 Chongqing medicine
关键词 链脲菌素 糖尿病 实验性 秋龙筋中药制剂 降糖作用 机制 streptozocin diabetes mellitus experimental Qiulongjin Chinese medicine preparation hypoglycemic effect mechanism
  • 相关文献

参考文献6

二级参考文献66

  • 1杨文英.从脂毒性到糖尿病再到血脂异常[J].国外医学(内分泌学分册),2004,24(4):287-288. 被引量:65
  • 2徐成斌.糖尿病血脂异常治疗进展(上)[J].中国医刊,2004,39(9):5-7. 被引量:17
  • 3周爱儒,查锡良.生物化学[M].5版.北京:人民卫生出版社,2001:74-78.
  • 4Hardie D G, Hawley S A, Scott J W. AMP-activated protein kinase development of the energy sensor concept. The Journal of Physiology, 2006, 574(1): 7-15.
  • 5Shibata R, Sato K, Pimentel D R, et a/, Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nature Medicine, 2005, 11 (10): 1096-1103.
  • 6Fruebis J, Tsao T S, Javorschi S, et ol. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA, 2001, 98(4): 2005-2010.
  • 7Lihn A S, Jessen N, Pedersen S B, et ~d. AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochemical And Biophysical Research Communications, 2004, 316 (3): 853- 858.
  • 8Drew" B G, Carey A L, Natoli A K, et d. Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus. Journal Of Lipid Research, 2011, 52(3): 572-581.
  • 9Orci L, Cook W S, Ravazzola M, et ~d. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA, 2004, 101(7): 2058-2063.
  • 10Gala L, Yah J, Liu Z, et td. Adiponectin prevents reduction of lipid-induced mitochondrial biogenesis vi~t AMPK/ACC2 pathway in chicken adipocyte. Journal of Cellular Biochemistry, 2015, 116(6): 1090 1100.

共引文献78

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部